Daina Vanags

1.5k total citations
17 papers, 1.2k citations indexed

About

Daina Vanags is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Daina Vanags has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Immunology and 3 papers in Pharmacology. Recurrent topics in Daina Vanags's work include Heat shock proteins research (5 papers), Cell death mechanisms and regulation (4 papers) and Phagocytosis and Immune Regulation (3 papers). Daina Vanags is often cited by papers focused on Heat shock proteins research (5 papers), Cell death mechanisms and regulation (4 papers) and Phagocytosis and Immune Regulation (3 papers). Daina Vanags collaborates with scholars based in Australia, Sweden and New Zealand. Daina Vanags's co-authors include Sten Orrenius, David H. Burgess, M. Isabella Pörn-Ares, Simona Coppola, Boris Zhivotovsky, Miguel Aguilar‐Santelises, Barbara J. Johnson, Mark B. Hampton, Andrew D. Clouston and Elizabeth E. Powell and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Daina Vanags

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daina Vanags Australia	12	725	327	197	166	144	17	1.2k
Christiane Ody France	21	808 1.1×	554 1.7×	122 0.6×	145 0.9×	211 1.5×	30	1.8k
Francesco Autuori Italy	19	549 0.8×	294 0.9×	96 0.5×	204 1.2×	214 1.5×	45	1.2k
Franck Galland France	22	831 1.1×	217 0.7×	95 0.5×	152 0.9×	90 0.6×	42	1.4k
Ni Cheng United States	22	777 1.1×	472 1.4×	145 0.7×	58 0.3×	153 1.1×	46	1.5k
Michèle Fay France	22	591 0.8×	968 3.0×	223 1.1×	153 0.9×	320 2.2×	28	1.8k
Peter Feick Germany	17	402 0.6×	156 0.5×	97 0.5×	248 1.5×	109 0.8×	31	898
Antonio Tugores Spain	18	550 0.8×	361 1.1×	78 0.4×	68 0.4×	131 0.9×	57	1.3k
Maria Ripoli Italy	17	565 0.8×	136 0.4×	271 1.4×	80 0.5×	99 0.7×	23	1.1k
Wim Van Molle Belgium	13	392 0.5×	239 0.7×	120 0.6×	85 0.5×	110 0.8×	20	909
Chunbin Zou United States	22	1.0k 1.4×	364 1.1×	271 1.4×	123 0.7×	80 0.6×	52	1.5k

Countries citing papers authored by Daina Vanags

Since Specialization

Citations

This map shows the geographic impact of Daina Vanags's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daina Vanags with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daina Vanags more than expected).

Fields of papers citing papers by Daina Vanags

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daina Vanags. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daina Vanags. The network helps show where Daina Vanags may publish in the future.

Co-authorship network of co-authors of Daina Vanags

This figure shows the co-authorship network connecting the top 25 collaborators of Daina Vanags. A scholar is included among the top collaborators of Daina Vanags based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daina Vanags. Daina Vanags is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nash, Peter, et al.. (2011). Efficacy and safety of subcutaneous recombinant chaperonin10 in patients with active rheumatoid arthritis despite methotrexate treatment. Queensland's institutional digital repository (The University of Queensland). 63(12). 4043–4043. 1 indexed citations

Broadley, Simon, Daina Vanags, Brett Williams, et al.. (2009). Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis.. PubMed. 15(3). 329–36. 1 indexed citations

Vanags, Daina, Bryan Williams, Barbara J. Johnson, et al.. (2008). Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis. Multiple Sclerosis Journal. 15(3). 329–336. 30 indexed citations

Vanags, Daina, Bronwyn Williams, Barbara J. Johnson, et al.. (2006). Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. The Lancet. 368(9538). 855–863. 101 indexed citations

Johnson, Barbara J., Thuy T. Le, Tatjana Banovic, et al.. (2004). Heat Shock Protein 10 Inhibits Lipopolysaccharide-induced Inflammatory Mediator Production. Journal of Biological Chemistry. 280(6). 4037–4047. 127 indexed citations

Walsh, Meagan J., Daina Vanags, Andrew D. Clouston, et al.. (2004). Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury. Hepatology. 39(5). 1230–1238. 120 indexed citations

Jonsson, Julie R., Wenyi Gu, Daina Vanags, et al.. (2004). Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transplantation. 10(3). 397–403. 4 indexed citations

Clouston, Andrew D., et al.. (2003). 566 Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression. Hepatology. 38. 433–433. 1 indexed citations

Vanags, Daina, J. V. Lloyd, Susan Rodgers, & Felix Bochner. (1998). ADP, adrenaline and serotonin stimulate inositol 1,4,5-trisphosphate production in human platelets. European Journal of Pharmacology. 358(1). 93–100. 11 indexed citations

10.

Vanags, Daina, Sten Orrenius, & Miguel Aguilar‐Santelises. (1997). Alterations in Bcl‐2/Bax protein levels in platelets form part of an ionomycin‐induced process that resembles apoptosis. British Journal of Haematology. 99(4). 824–831. 110 indexed citations

11.

Zhivotovsky, Boris, David H. Burgess, Daina Vanags, & Sten Orrenius. (1997). Involvement of Cellular Proteolytic Machinery in Apoptosis. Biochemical and Biophysical Research Communications. 230(3). 481–488. 171 indexed citations

12.

Vanags, Daina, Pontus Larsson, Stina Feltenmark, et al.. (1997). Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells. Cell Death and Differentiation. 4(6). 479–486. 14 indexed citations

13.

Zhivotovsky, Boris, David H. Burgess, Jörg Schlegel, et al.. (1997). Proteases in Fas‐mediated apoptosis. Journal of Cellular Biochemistry. 64(1). 43–49. 15 indexed citations

14.

Hampton, Mark B., Daina Vanags, M. Isabella Pörn-Ares, & Sten Orrenius. (1996). Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Letters. 399(3). 277–282. 98 indexed citations

15.

Vanags, Daina, M. Isabella Pörn-Ares, Simona Coppola, David H. Burgess, & Sten Orrenius. (1996). Protease Involvement in Fodrin Cleavage and Phosphatidylserine Exposure in Apoptosis. Journal of Biological Chemistry. 271(49). 31075–31085. 350 indexed citations

16.

Vanags, Daina, Susan Rodgers, Elizabeth M. Duncan, J. V. Lloyd, & Felix Bochner. (1992). Potentiation of ADP‐induced aggregation in human platelet‐rich plasma by 5‐hydroxytryptamine and adrenaline. British Journal of Pharmacology. 106(4). 917–923. 39 indexed citations

17.

Vanags, Daina, Susan Rodgers, J. V. Lloyd, & Felix Bochner. (1990). The antiplatelet effect of daily low dose enteric-coated aspirin in man: A time course of onset and recovery. Thrombosis Research. 59(6). 995–1005. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact